2018年3月
Tumor Hypoxia Detected by F-18-fluoromisonidazole Positron Emission Tomography (FMISO PET) as a Prognostic Indicator of Radiotherapy (RT)
ANTICANCER RESEARCH
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- ,
- 巻
- 38
- 号
- 3
- 開始ページ
- 1775
- 終了ページ
- 1781
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.21873/anticanres.12415
- 出版者・発行元
- INT INST ANTICANCER RESEARCH
Background/Aim: F-18-misonidazole positron emission tomography (FMISO PET)/computed tomography (CT) obtained before and during radiotherapy (RT) was analyzed as to whether it could predict clinical outcome. Patients and Methods: Twenty-two patients were included. FMISO PET/CT was performed twice before RT and at a dose of approximately 20 Gy/10 fractions. FMISO maximum standardized uptake values (SUVmax), the tumor-to-muscle ratios (T/M), and hypoxic volume (HV) in gross target volumes were measured. Results: Of the 22 tumors, 18 had hypoxic areas (SUVmax = 1.60) before RT. SUVmax, T/M, and HV on the first PET/CT were significantly correlated with initial tumor response, although the values during RT were not related to the response. The overall survival and locoregional control rates of patients below cut-off values were significantly better than those above the cut-off values. Conclusion: Tumor hypoxia detected by FMISO PET/CT before RT may predict clinical outcome.
- リンク情報
- ID情報
-
- DOI : 10.21873/anticanres.12415
- ISSN : 0250-7005
- eISSN : 1791-7530
- PubMed ID : 29491116
- Web of Science ID : WOS:000428794300073